These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


157 related items for PubMed ID: 27189349

  • 1. Antagonism of Endothelin (ETA and ETB) Receptors During Renovascular Hypertension-Induced Vascular Dementia Improves Cognition.
    Singh P, Gupta S, Sharma B.
    Curr Neurovasc Res; 2016; 13(3):219-29. PubMed ID: 27189349
    [Abstract] [Full Text] [Related]

  • 2. Selective Serotonin-norepinephrine Re-uptake Inhibition Limits Renovas-cular-hypertension Induced Cognitive Impairment, Endothelial Dysfunction, and Oxidative Stress Injury.
    Singh P, Sharma B.
    Curr Neurovasc Res; 2016; 13(2):135-46. PubMed ID: 26915517
    [Abstract] [Full Text] [Related]

  • 3. Melatonin receptor and KATP channel modulation in experimental vascular dementia.
    Singh P, Gupta S, Sharma B.
    Physiol Behav; 2015 Apr 01; 142():66-78. PubMed ID: 25659733
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy of bosentan, a dual ETA and ETB endothelin receptor antagonist, in experimental diabetes induced vascular endothelial dysfunction and associated dementia in rats.
    Singh G, Sharma B, Jaggi AS, Singh N.
    Pharmacol Biochem Behav; 2014 Sep 01; 124():27-35. PubMed ID: 24836182
    [Abstract] [Full Text] [Related]

  • 7. Salubrious effects of ulinastatin and quercetin alone or in combination in endothelial dysfunction and vascular dementia.
    Sharma P, Gaur N, Jayant S, Sharma BM, Singh B, Kharkwal H, Sharma B.
    Pharmacol Rep; 2022 Jun 01; 74(3):481-492. PubMed ID: 35396697
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Salutary effect of NFκB inhibitor and folacin in hyperhomocysteinemia-hyperlipidemia induced vascular dementia.
    Sharma B, Singh N.
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug 07; 38(2):207-15. PubMed ID: 22510463
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Experimental hypertension induced vascular dementia: pharmacological, biochemical and behavioral recuperation by angiotensin receptor blocker and acetylcholinesterase inhibitor.
    Sharma B, Singh N.
    Pharmacol Biochem Behav; 2012 Jul 07; 102(1):101-8. PubMed ID: 22507914
    [Abstract] [Full Text] [Related]

  • 17. Antihypertensive and antioxidant effects of a single daily dose of sodium nitrite in a model of renovascular hypertension.
    Montenegro MF, Pinheiro LC, Amaral JH, Marçal DM, Palei AC, Costa-Filho AJ, Tanus-Santos JE.
    Naunyn Schmiedebergs Arch Pharmacol; 2012 May 07; 385(5):509-17. PubMed ID: 22262021
    [Abstract] [Full Text] [Related]

  • 18. Regular exercise alleviates renovascular hypertension-induced cardiac/endothelial dysfunction and oxidative injury in rats.
    Kumral ZN, Sener G, Ozgur S, Koc M, Suleymanoglu S, Hurdag C, Yegen BC.
    J Physiol Pharmacol; 2016 Feb 07; 67(1):45-55. PubMed ID: 27010894
    [Abstract] [Full Text] [Related]

  • 19. Arsenic toxicity induced endothelial dysfunction and dementia: pharmacological interdiction by histone deacetylase and inducible nitric oxide synthase inhibitors.
    Sharma B, Sharma PM.
    Toxicol Appl Pharmacol; 2013 Nov 15; 273(1):180-8. PubMed ID: 23921152
    [Abstract] [Full Text] [Related]

  • 20. Ozagrel a thromboxane A2 synthase inhibitor extenuates endothelial dysfunction, oxidative stress and neuroinflammation in rat model of bilateral common carotid artery occlusion induced vascular dementia.
    Bhatia P, Kaur G, Singh N.
    Vascul Pharmacol; 2021 Apr 15; 137():106827. PubMed ID: 33346090
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.